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When ingested alone, beetroot juice and sodium bicarbonate are ergogenic for high-intensity exercise per-
formance. This study sought to determine the independent and combined effects of these supplements. Eight 
endurance trained (VO2max 65 mL·kg·min-1) male cyclists completed four × 4-km time trials (TT) in a double-
blind Latin square design supplementing with beetroot crystals (BC) for 3 days (15 g·day-1 + 15 g 1 h before 
TT, containing 300 mg nitrate per 15 g), bicarbonate (Bi 0.3 g·kg-1 body mass [BM] in 5 doses every 15 min 
from 2.5 h before TT); BC+Bi or placebo (PLA). Subjects completed TTs on a Velotron cycle ergometer 
under standardized laboratory conditions. Plasma nitrite concentrations were significantly elevated only in 
the BC+Bi trial before the TT (1520 ± 786 nmol·L-1) compared with baseline (665 ± 535 nmol·L-1, p = .02) 
and the Bi and PLA conditions (Bi: 593 ± 203 nmol·L-1, p < .01; PLA: 543 ± 369 nmol·L-1, p < .01). Plasma 
nitrite concentrations were not elevated in the BC trial before the TT (1102 ± 218 nmol·L-1) compared with 
baseline (975 ± 607 nmol·L-1, p > .05). Blood bicarbonate concentrations were increased in the BC+Bi and 
Bi trials before the TT (BC+Bi: 30.9 ± 2.8 mmol·L-1; Bi: 31.7 ± 1.1 mmol·L-1). There were no differences in 
mean power output (386–394 W) or the time taken to complete the TT (335.8–338.1 s) between any conditions. 
Under the conditions of this study, supplementation was not ergogenic for 4-km TT performance.
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Despite plentiful literature on the effects of various 
nutritional ergogenic aids on sports performance, the 
real-life scenario in which several supplements are used in 
combination is relatively unexplored. Two substances that 
are widely used and have received scientific attention in 
high-intensity events lasting 4–8 min are inorganic nitrate 
(NO3-) and sodium bicarbonate (NaHCO3). Dietary NO3-, 
often consumed as beetroot juice, increases the bioavail-
ability of the signaling molecule nitric oxide (NO) via the 
NO3--NO2--NO pathway, particularly under conditions of 
hypoxia and metabolic acidosis (De Smet et al., 2016; 
Kelly et al., 2014; Vanhatalo et al., 2011). NO’s effects 
on physiological functions such as blood flow, muscle 
oxidative metabolism and mitochondrial biogenesis 
(Lee et al., 2015; Vaughan et al., 2016) may contribute 
to observations of improved athletic performance, par-
ticularly in shorter, high-intensity activities (De Smet 
et al., 2016; Lansley et al., 2011). Meanwhile, several 
studies report a modest benefit of the alkalizing agent 
NaHCO3 on the performance of high-intensity exercise 
(Kilding et al., 2012) via an increased capacity to buffer 
hydrogen ions (H+) produced by anaerobic glycolysis 
(Carr et al., 2011a).
Evidence of independent benefits and mechanisms 
of action in relation to the performance of high-intensity 
sports encourage athletes in these events to supplement 
with both dietary NO3- and NaHCO3, for a potential addi-
tive effect. However, it is also possible that coingestion 
of any two supplements might be counter-productive 
due to side-effects or antagonistic biochemistry (i.e., 
one blunts the effect of the other). In this case, NaHCO3 
supplementation might counteract the acidosis under 
which the NO3--NO2--NO pathway provides an impor-
tant source of NO production. This study investigated 
the single and combined effects of NO3- rich beetroot 
crystals and NaHCO3 supplementation on a 4-km cycling 
time-trial (TT).
Methods
Eight well-trained male cyclists (34 ± 7 y, 73.8 ± 10.1 
kg, VO2max: 65.2 ± 4.2 mL·kg-1·min-1, BMI: 22.3 ± 2.0 
kg·m-2) provided informed consent to participate in this 
study, approved by the Australian Catholic University 
Human Research Ethics Committee and registered on 
the Australian New Zealand Clinical Trials Registry 
(ACTRN12614000670673). We implemented a double-
blind, placebo-controlled, Latin square application of four 
treatments separated by a 7-day wash out period between 
each trial: bicarbonate + beetroot crystals (BC+Bi), bicar-
bonate + placebo beetroot crystals (Bi), beetroot crystals 
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+ placebo bicarbonate (BC) and placebo beetroot crystals 
+ placebo bicarbonate (PLA). The manufacturer’s recom-
mended BC treatment (packed into gelatin capsules) and 
color-matched placebo (90% BeetEssence, Green Foods 
Corp., CA, USA; 10% Black Cherry Kool-Aid, Kraft 
Foods Group Inc., IL, USA, packed into gelatin capsules) 
involved subjects completing a three-day loading protocol 
(15 g·d-1 containing 300 mg or ~5 mmol NO3- ingested 
at ~2000 hr), plus an acute dose (15 g) on trial morning, 
mixed with 400 mL water and consumed 1 hr pre time-
trial (TT). Subjects were instructed not to spit or chew 
gum during supplementation and to avoid antibacterial 
mouth rinses and routine oral hygiene practices for 90 
min after ingesting the capsules. These restrictions were 
implemented so that commensal bacteria present in the 
oral cavity important for the reduction of NO3- to NO2- 
were not completely eradicated (Govoni et al., 2008). 
Bicarbonate (HCO3-) (sodium bicarbonate, McKenzie 
Pty. Ltd, Australia) or placebo (75% maltodextrin, 25% 
sodium chloride) supplementation occurred on trial day, 
with the encapsulated dose (0.3 g·kg BM -1) ingested in 
five equal amounts every 15 min, commencing 150 min 
before the TT.
Subjects visited the laboratory (46 m above sea level) 
on nine occasions. Preliminary testing and familiarization 
consisted of three phases. First, subjects completed an 
incremental cycling test commenced at a power output 
of 150 W with 50 W increases each subsequent 5 min to 
determine the power output to be used in experimental 
trials. Capillary blood samples were taken from the 
earlobe during the final 30 s of each work rate for the 
determination of lactate concentration. The test was 
stopped once a lactate concentration of >4–7 mmol·L-1 
was attained. Subjects then completed 10 min of cycling 
at 150 W then dismounted the ergometer (Velotron, Rac-
ermate Inc, Seattle, USA) and rested in the laboratory 
for a further 10 min. Phase two of preliminary testing 
commenced once a blood lactate concentration <2.5 
mmol·L-1 had been measured, and consisted of a maxi-
mal 4-min cycling TT for the determination of VO2peak. 
An earlobe blood lactate sample was taken immediately 
after exercise followed by a rest period identical to the 
first. Lastly, subjects completed a familiarization 4-km 
TT identical to those performed during the subsequent 
experimental trials. For all three phases of preliminary 
testing and familiarization, subjects wore a mouthpiece 
(Hans Rudolph Inc., USA) connected to an automated 
online gas analyzer (True One 2400 Metabolic Mea-
surement System, Parvo Medics, USA) for collection of 
respiratory gases.
Subjects visited the laboratory 72 hr pretrial for 
blood collection. Strict diet-exercise control was then 
implemented until trial day, including avoidance of oral 
mouthwashes and consumption of a standardized pre-
packaged diet (210 kJ·kg BM-1, 8 g·kg BM-1 carbohydrate 
(CHO); 2.0 g·kg BM-1 protein; 1.0 g·kg BM-1 fat) for the 
last 24 hr (Jeacocke & Burke, 2010). On trial morning 
(Figure 1), subjects reported overnight-fasted, completed 
a compliance check, and were cannulated via a forearm 
vein. All subjects completed each trial at the same time 
(± two h). Subjects completed a gastrointestinal (GI) 
distress questionnaire then consumed a standardized meal 
(2 g·kg BM-1 CHO) with the first NaHCO3/placebo dose 
(150 min pre-TT). The same questionnaire was completed 
65-min prior, 5-min prior, 6-min post and 81-min post TT 
and has been reported in another study to discriminate 
GI problems (Carr et al., 2011b). Sixty minutes before 
the TT, subjects ingested the BC/placebo supplement, 
then after a further 15 min mounted the cycle ergometer 
and commenced a warm-up (50, 70, 85 and 100% of 
individual anaerobic threshold for 8, 5, 3 and 3 min + 
5 min at 100 W + 1 min build-up to average TT power, 
sustained for 30 s). After a 15 min rest and consumption 
of a sports gel (27 g CHO; Powerbar Inc., Florham Park, 
USA), subjects then undertook the TT; a 4-km all-out 
effort to which they had been familiarized.
Six venous blood samples (6 mL) were collected 
in EDTA tubes per trial: baseline (72 hr prior) and 
five trial-day samples (see Figure 1). Blood [glucose], 
[lactate] (YSI 2300, Life Sciences, OH, USA), [HCO3-] 
and pH (i-STAT, Princeton, NJ, USA) were determined 
immediately, while plasma was collected (centrifuged 
at 3000 rpm for 10 min), aliquoted and stored at -80 
°C for analysis of [NO3-] and [NO2-]. Complete ana-
lytical procedures for NO3-/NO2- via the ENO-20 HPLC 
System (EiCom Corporation, USA) have been previously 
described (Bryan & Grisham, 2007).
Statistical analyses were undertaken using SPSS 
(Version 22) software. Comparisons between trials, 
performance and physiological measures involved a 
linear mixed model, while within-condition compari-
sons involved repeated measures analysis of variance 
with Bonferroni adjustment. Significance was set at p 
< .05. Data are presented as mean ± SD. Data for time 
to completion were analyzed between conditions using 
magnitude based inferences by calculating the percent-
age difference ±90% confidence limits (Hopkins, 2006). 
Chances that the true value of the statistic was positive, 
trivial or negative relative to the smallest important value 
(1%; (Paton & Hopkins, 2006) was based on the following 
scale: <0.5%, almost certainly not; <5%, very unlikely; 
<25%, unlikely, probably not; 25–75%, possibly, possibly 
not; >75%, likely, probably; >95%, very likely; >99.5%, 
almost certainly (Hopkins, 2006). When there was a >5% 
chance of the statistic being both positive and negative, 
the effect was deemed unclear.
Results
There was no effect of trial treatment or order on perfor-
mance parameters (Table 1; Figure 2).  The coefficient 
of variation (CV) for time (m:s) for each subject across 
all four trials was calculated and resulted in a group mean 
of 0.7 ± 0.4%. Percentage changes between group means 
revealed trivial differences between each of the conditions 
(Tables 2 and 3). Plasma [NO3-] and [NO2-] (Figure 3), 
blood [HCO3-] and pH (Figure 4) all returned to baseline 
Nitrate, Sodium Bicarbonate, and Cycling Time Trial Performance 173
Figure 1 — Schematic figure of experimental design. After 24 h of exercise and dietary control, each subject undertook four trials 
of simulated 4 km all-out cycling time-trials (TTs). Subjects completed these in a double-blind, placebo-controlled, Latin square 
design, one week apart: bicarbonate + beetroot crystals (BC+Bi), bicarbonate + placebo beetroot crystals (Bi), beetroot crystals + 
placebo bicarbonate (BC) and placebo beetroot crystals + placebo bicarbonate (PLA). Following a standardized meal (2 g·kg BM-1 
CHO) the first HCO3-/placebo dose (150 min pre-TT) was consumed, 60 min pre TT, subjects ingested the BC/placebo supplement, 
then a further 15 min after commenced a warm-up (50, 70, 85 and 100% of individual anaerobic threshold for 8, 5, 3 and 3 min + 5 
min at 100 W + 1 min build-up to average TT power, sustained for 30 s), and 15 min before the TT subjects consumed a sports gel 
(27 g CHO). Blood samples were obtained 72 h prior and five times on trial day.
Figure 2 — Mean and individual time to completion data for 
4-km cycling time trial.
values at the commencement of each pretrial period. The 
3-day NO3- preload tended to increase plasma [NO3-] at 
rest compared with baseline (BC+Bi: +54 ± 65 mmol·L-1; 
BC: +77 ± 52 mmol·L-1, Figure 3A). The acute trial day 
dose increased plasma [NO3-] from rest to pre-TT for 
the BC trials (BC+Bi: +198 ± 40 mmol·L-1; BC: +179 
± 55 mmol·L-1) compared with the nonsupplemented 
trials (Bi: +24 ± 42; PLA: +9 ± 12 mmol·L-1) such that 
plasma [NO3-] in the BC trials was significantly greater 
than baseline (p < .01, Figure 3A). NO3- supplementa-
tion increased plasma [NO2-] at pre-TT only in BC+Bi 
compared with baseline (p = .02) and nonsupplemented 
trials (Bi: +928 ± 879 nmol·L-1, p < .01; vs. PLA: +978 
± 748 nmol·L-1, p < .01, Figure 3B).
Blood [HCO3-] increased with NaHCO3 supple-
mentation at pre-TT (Figure 4C) and decreased in all 
trials post-TT (BC+Bi: -9.4 ± 2.6 mmol·L-1; Bi: -11.4 
± 3.7 mmol·L-1; BC: -8.9 ± 2.3 mmol·L-1; PLA: -6.6 
± 1.5 mmol·L-1, p < .01). Blood [HCO3-] remained 
elevated above resting values at 75 min post-TT in the 
NaHCO3 trials (BC+Bi: +4.3 ± 0.2 mmol·L-1; Bi: +4.4 
± 0.6 mmol·L-1, p < .01). Blood pH values mirrored 
these results (Figure 4D). BC+Bi and Bi trials resulted 
in higher blood [lactate] post-TT compared with BC 
and PLA (p < .01; Figure 4A). Blood [glucose] did not 
differ between trials (Figure 4B). A questionnaire on 
gastrointestinal distress on trial days revealed no cases 
of gastrointestinal disturbance (data not shown).
Discussion
The results of the current study are the first to demonstrate 
the single and combined effects of supplementation with 
NO3- and NaHCO3 on a simulated track cycling event. We 
used protocols designed to achieve physiological changes 
favorable for high-intensity exercise lasting ~4–6 min 
(Hoon et al., 2014; Kilding et al., 2012). Specifically, our 
cyclists consumed chronic plus acute doses of NO3- rich 
beetroot crystals (300 mg NO3- per 15 g for three days 
and 15 g 1 hr preexercise) and a well-tolerated alkalizing 
protocol (0.3 g·kg BM-1 NaHCO3 in five doses, com-
mencing 2.5 hr preexercise) (Carr et al., 2011b). Despite 
changes in plasma [NO3-] and blood [HCO3-], we failed 
to find enhancement of a laboratory-based 4-km cycling 
TT with either supplement or their combination. Careful 
experimental design (well-trained subjects, performance 
familiarization, control of pretrial training, standardized 
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pretrial diets, supervised supplementation) provides 
confidence in the reliability of our performance data.
NaHCO3 loading can enhance the performance of 
laboratory-based cycling (4-min TT; Bellinger et al., 
2012; 3-km TT; Kilding et al., 2012), and other labora-
tory or field protocols of similar duration and intensity 
(e.g., 2000-m rowing ergometer TT (Hobson et al., 2014); 
1500-m running (Bird et al., 1995)).  Indeed, a meta-
analysis of NaHCO3 loading and sports performance 
found a possibly moderate enhancement of 1.7% (90% 
CL ± 2.0%) in a 1-min sprint following blinded consump-
tion of 0.3 g·kg-1 BM NaHCO3 by male athletes that is 
reduced with each 10-fold increase in test duration by 
0.6% (±0.9%) (Carr et al., 2011a). Increases in preexer-
cise blood [HCO3-] were identified as a determinant of 
performance benefits. Similarly, NO3-supplementation 
was shown by meta-analysis to provide a trivial but non-
significant benefit for TT performance (ES = -0.10, 95% 
CI: -0.27–0.06), with NO3- dose (+8 mmol) and type of 
exercise (higher vs. lower intensity) being factors likely 
to increase the benefit (Jones, 2014b; McMahon et al., 
2016; Wylie et al., 2013). Of specific interest to our study, 
Lansley and colleagues (2011) reported a 2.8% enhance-
ment of a 4-km TT in club-level cyclists following acute 
supplementation with 0.5 L beetroot juice containing 
~6.2 mmol of NO3-.
We are not alone in failing to find performance 
benefits from either of the supplements examined in the 
current investigation. Others have failed to find ergogenic 
outcomes associated with NO3- supplementation in a 
similar cycling protocol in competitive cyclists (Hoon 
et al., 2014), or other exercise protocols of similar dura-
tion, such as a 1500-m run (Boorsma et al., 2014). The 
magnitude of plasma [NO3-]/[NO2-] increases (Hoon et 
al., 2014; Wilkerson et al., 2012; Wylie et al., 2013) and 
apparently different responses in highly-trained vs. lower-
caliber athletes (Porcelli et al., 2015) may underpin these 
observations. Specifically, a lower proportion of Type II 
muscle fibers which are more responsive to NO3- supple-
mentation, higher baseline NO2- status due to endogenous 
production via the NOS pathway, and better oxygenation 
of muscles in highly trained individuals may reduce the 
importance of an enhanced NO3-/NO2-/NO pathway 
(Jones, 2014b). Analysis of plasma [NO2-] provide direct 
evidence of several important methodological aspects of 
our work: NO2- status returned to baseline in the 3-day 
washout between trials, and the combination of preload 
and acute supplementation before the TT achieved large 
increases in plasma [NO3-], at greater levels than achieved 
previously where NO3- supplementation was shown to 
enhance 4-km TT performance (Lansley et al., 2011). 
Furthermore, plasma [NO2-] reported in the current study 
were greater than those seen in another investigation 
also using a three-day loading protocol (BC+Bi, 1521 
nmol·L-1; BC, 1102 vs. 334 nmol·L-1) (Bescos et al., 
2012). However, we do acknowledge some anomalies 
with our data: the baseline levels of plasma [NO2-] were 
higher than that reported in other studies (~200–300 
nM, (Hoon et al., 2014; Lansley et al., 2011)) and were 
only elevated for the TT in the case of the BC+Bi trial. 
Therefore, the difficulty in achieving a performance 
enhancement with the BC may reside with the inability 
of this dose to further raise the already high NO2- levels 
in our well-trained population. Indeed, we acknowledge 
that the acute dose used on the day of the TT is lower than 
the amounts others have shown to be optimal (Wylie et 
al., 2013), that acute doses are typically taken 2–2.5 hr 
preevent rather than 60 min, and that greater doses may 
be needed in highly trained subjects compared with rec-
reational athletes (Jones, 2014b). However, the protocol 
chosen for this study followed the dose recommended by 
the manufacturer and provided a three-day preload to try 
to increase background NO availability before the final 
dose. Whether there was interaction with HCO3- supple-
mentation to decrease the importance of enhanced NO3-/
NO2- concentrations in the face of reduced metabolic 
acidosis cannot be detected in this study but presents 
Figure 3 — Plasma NO3- (A) and NO2- (B) concentrations mea-
sured in well-trained male cyclists (n = 8) during 4-km cycling 
time trials. Significantly different: a, BC+Bi vs. PLA; c, BC+Bi 
vs. Bi; d, BC vs. PLA; e, BC vs. Bi; *, BC+Bi different from 
baseline; †, BC different from baseline. Data are mean ± SD.
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Figure 4 — Blood lactate concentrations (A), glucose concentrations (B), HCO3- concentrations (C), and pH (D) measured in well-
trained male cyclists (n = 8) during 4-km cycling time trials. Significantly different: a, BC+Bi vs. PLA; b, BC+Bi vs. BC; e, BC 
vs. Bi; f, Bi vs. PLA; #, all trials different from pre TT, ^, BC+Bi different from rest; §, Bi different from rest. Data are mean ± SD.
Table 1 Mean ± SD for Mean Power Output and Heart Rate During 4-km 
Cycling TT
Condition
Mean Power Output Mean time to 
Completion (s)
Mean Heart Rate
(W) (W·kg-1) (beats·min-1)
PLA 386 ± 55 5.25 ± 0.51 338.10 ± 18.04 171 ± 11
BC 388 ± 54 5.28 ± 0.47 337.41 ± 17.11 169 ± 13
Bi 394 ± 52 5.37 ± 0.52 335.78 ± 16.94 172 ± 11
BC+Bi 393 ± 54 5.33 ± 0.53 336.10 ± 17.28 175 ± 7
Table 2 Effect of Nitrate and Bicarbonate Supplementation on 4-km 
Cycling Time Trial Time to Completion Compared with Placebo
Condition
Change in Mean Compared with Placebo
(%, ±90% CL) Nonclinical Inferencea
BC -0.2 ± 0.6 very likely trivial
Bi -0.7 ± 1.1 possibly trivial
BC+Bi -0.6 ± 0.4 likely trivial
aChances that the true value of the statistic was positive, trivial or negative relative to the smallest important value 
of 1% was based on the following scale: < 0.5%, almost certainly not; < 5%, very unlikely; < 25%, unlikely, prob-
ably not; 25–75%, possibly, possibly not; > 75%, likely, probably; > 95%, very likely; > 99.5%, almost certainly. 
When there was a > 5% chance of the statistic being both positive and negative, the effect was deemed unclear.
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another contributing factor to the lack of efficacy of the 
combined supplementation protocol.
Despite significant elevation of blood [HCO3-] and 
pH before exercise and blood lactate immediately fol-
lowing exercise, we failed to detect a clear performance 
benefit of NaHCO3 loading on a 4-km cycling TT (~5.5 
min). Indeed, this is similar to findings from other 
studies involving exercise protocols of similar duration 
(Carr et al., 2011c; Christensen et al., 2014; Kupcis et 
al., 2012) and again demonstrates that certain conditions 
such as high intensity short-duration (~1-min) events 
involving repeated efforts may be needed before clear 
benefits are seen (Sutton et al., 1981). Although benefits 
provided by NaHCO3 loading may be counteracted by 
the potentially associated gastrointestinal distress, this 
risk can be reduced by the use of specific protocols 
involving encapsulated supplements, a spread intake, 
and coingestion with a light carbohydrate meal (Carr et 
al., 2011b). These conditions were implemented in the 
current study; indeed, no gut problems were reported by 
our subjects. Blood lactate concentrations were shown to 
be higher in the NaHCO3 conditions following the 4-km 
TT (Figure 4C) indicating increased energy production 
by anaerobic glycolysis however no performance benefits 
were observed. The lack of efficacy of NaHCO3 supple-
mentation may be due to insufficient buffering capacity 
despite induced muscle alkalosis (Sutton et al., 1981), 
fatigue unrelated to acidosis (Cairns, 2006) or improved 
anaerobic capacity in well-trained subjects (Medbo & 
Burgers, 1990). A novel finding of our study was the 
maintenance of elevated blood [HCO3-], 75 min after the 
performance bout. This may be meaningful for athletes 
who compete in multiple events in a single session as 
our results suggest no need to redose with NaHCO3 for 
events 75 min apart.
In conclusion, ingestion of a validated NaHCO3 
protocol or the manufacturer’s recommended protocol 
of intake of an inorganic NO3- product failed to enhance 
the performance of 4-km cycling TT by well-trained 
cyclists, either alone or in combination. Although it is 
possible that the combined use of two supplements, each 
of which is known to have ergogenic effects when used 
individually, could have an additive effect, the work-
ing hypothesis of this study was that there would be an 
interference effect, with NaHCO3 removing one of the 
physiological conditions under which dietary NO3- might 
be efficacious. The findings of this investigation do not 
exclude the possibility that either or both supplements 
are ergogenic under different conditions, or that alkalosis 
achieved by NaHCO3 loading might reduce the efficacy 
of NO3- supplementation Future research should continue 
to investigate supplementation of dietary NO3- in combi-
nation with other nutritional aids in well-trained popula-
tions, since the real life practices of athletes commonly 
include the parallel use of several different supplements. 
Specifically, exercise scenarios that induce metabolic 
acidosis or hypoxia may favor the physiological effects 
of the NO3--NO2--NO pathway and should be targeted 
for further research with dietary NO3-supplementation. 
When these are better identified, there will be opportunity 
to investigate the potential interactive effects of achieving 
alkalosis via NaHCO3 supplementation protocols.
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